Cargando…
Transforming Growth Factor-Beta1 in Diabetic Kidney Disease
Diabetic kidney disease (DKD) is the leading cause of end-stage renal disease (ESRD) worldwide. Renin-angiotensin-aldosterone system (RAAS) inhibitors and sodium-glucose co-transporter 2 (SGLT2) inhibitors have shown efficacy in reducing the risk of ESRD. However, patients vary in their response to...
Autores principales: | Zhao, Lijun, Zou, Yutong, Liu, Fang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7105573/ https://www.ncbi.nlm.nih.gov/pubmed/32266267 http://dx.doi.org/10.3389/fcell.2020.00187 |
Ejemplares similares
-
Paradoxical Roles of Leucine-Rich α(2)-Glycoprotein-1 in Cell Death and Survival Modulated by Transforming Growth Factor-Beta 1 and Cytochrome c
por: Jemmerson, Ronald
Publicado: (2021) -
Transforming Growth Factor (TGF) β and Endometrial Vascular Maturation
por: Lu, Qinsheng, et al.
Publicado: (2021) -
Transforming Growth Factor-β: An Agent of Change in the Tumor Microenvironment
por: Stuelten, Christina H., et al.
Publicado: (2021) -
Extracellular Vesicles and Transforming Growth Factor β Signaling in Cancer
por: Rodrigues-Junior, Dorival Mendes, et al.
Publicado: (2022) -
Mitophagy in Diabetic Kidney Disease
por: Zhang, Xiaofeng, et al.
Publicado: (2021)